InterCure Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was ILS 355.55 million compared to ILS 388.68 million a year ago. Net loss was ILS 61.96 million compared to net income of ILS 44.82 million a year ago.

Basic loss per share from continuing operations was ILS 1.36 compared to basic earnings per share from continuing operations of ILS 0.99 a year ago. Diluted loss per share from continuing operations was ILS 1.36 compared to diluted earnings per share from continuing operations of ILS 0.99 a year ago.